Richard A Md Miller insider trades: Corvus Pharmaceuticals (CRVS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
26 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | CRVS | ↑ Buy | 6,932 | $12.04 | $83K | By Trust | May 20, 2026 (2d) |
| May 6, 2024 | CRVS | ↑ Buy | 577,634 | $1.73 | $1000K | Direct | May 7, 2024 (1d) |
| Dec 14, 2022 | CRVS | ↑ Buy | 60,000 | $0.75 | $45K | By Trust | Dec 15, 2022 (1d) |
| Sep 28, 2022 | CRVS | ↑ Buy | 25,000 | $0.76 | $19K | By Trust | Sep 28, 2022 (0d) |
| Sep 20, 2022 | CRVS | ↑ Buy | 20,000 | $0.81 | $16K | By Trust | Sep 20, 2022 (0d) |
| Jun 27, 2022 | CRVS | ↑ Buy | 10,000 | $1.01 | $10K | By Trust | Jun 28, 2022 (1d) |
| Jun 6, 2022 | CRVS | ↑ Buy | 5,890 | $0.98 | $6K | By Trust | Jun 6, 2022 (0d) |
| Mar 31, 2022 | CRVS | ↑ Buy | 15,000 | $1.64 | $25K | By Trust | Apr 1, 2022 (1d) |
| Mar 17, 2022 | CRVS | ↑ Buy | 30,000 | $1.49 | $45K | By Trust | Mar 17, 2022 (0d) |
| Aug 20, 2021 | CRVS | ↑ Buy | 10,000 | $1.93 | $19K | By Trust | Aug 23, 2021 (3d) |
| May 4, 2021 | CRVS | ↑ Buy | 35,714 | $2.80 | $100K | Direct | May 5, 2021 (1d) |
| Feb 17, 2021 | CRVS | ↑ Buy | 100,000 | $3.50 | $350K | By Trust | Feb 17, 2021 (0d) |
| Nov 13, 2019 | CRVS | ↑ Buy | 15,008 | $3.00 | $45K | By Trust | Nov 14, 2019 (1d) |
| Aug 7, 2019 | CRVS | ↑ Buy | 7,500 | $3.56 | $27K | By Trust | Aug 8, 2019 (1d) |
| Jun 14, 2019 | CRVS | ↑ Buy | 12,000 | $3.41 | $41K | By Trust | Jun 17, 2019 (3d) |
| Jun 11, 2019 | CRVS | ↑ Buy | 15,212 | $3.49 | $53K | By Trust | Jun 11, 2019 (0d) |
| Dec 27, 2018 | CRVS | ↑ Buy | 20,000 | $3.29 | $66K | By Trust | Dec 31, 2018 (4d) |
| Dec 20, 2018 | CRVS | ↑ Buy | 10,000 | $4.39 | $44K | By Trust | Dec 26, 2018 (6d) |
| Dec 6, 2018 | CRVS | ↑ Buy | 5,000 | $5.99 | $30K | By Trust | Dec 10, 2018 (4d) |
| Dec 4, 2018 | CRVS | ↑ Buy | 1,502 | $5.95 | $9K | By Trust | Dec 6, 2018 (2d) |
| Mar 12, 2018 | CRVS | ↑ Buy | 100,000 | $8.50 | $850K | By Trust | Mar 12, 2018 (0d) |
| Nov 20, 2017 | CRVS | ↑ Buy | 10,000 | $10.79 | $108K | By Trust | Nov 22, 2017 (2d) |
| Jun 13, 2017 | CRVS | ↑ Buy | 25,000 | $9.88 | $247K | By Trust | Jun 13, 2017 (0d) |
| May 13, 2016 | CRVS | ↑ Buy | 30,300 | $10.00 | $303K | By Trust | May 16, 2016 (3d) |
| Aug 22, 2007 | PCYC | ↑ Buy | 5,000 | $2.00 | $10K | Direct | Aug 22, 2007 (0d) |
| Aug 21, 2007 | PCYC | ↑ Buy | 5,000 | $2.00 | $10K | Direct | Aug 22, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRVS insiders
Open-market trades in the last 12 months
About Richard A Md Miller's insider trades
Richard A Md Miller is President and CEO at Corvus Pharmaceuticals (CRVS). Since Aug 21, 2007, Richard has reported 26 open-market purchases worth $3.6M and no sales on SEC Form 4. In the last 12 months: 1 buy ($83K).
Their filings also include grants and awards (20 filings), option exercises (2 filings), gifts (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.